Dalbavancin Hydrochloride (Dalbavancin HCL)
171500-79-1
Product Name: Dalbavancin Hydrochloride
Product Code: HWSWYSDBWX
Specification: 99%
Certifications：ISO,GMP
Product grade:USP
Delivery：Shipped on the same day from stocks
MOQ：1KG
Product Code: HWSWYSDBWX
Specification: 99%
Certifications：ISO,GMP
Product grade:USP
Delivery：Shipped on the same day from stocks
MOQ：1KG
Product Name | Dalbavancin Hydrochloride | |||
Appearance | White powder | |||
Specification | 99% | |||
Test Method | HPLC | |||
Storage | Keep in a cool, dry, dark location in a tightly sealed container or cylinder. | |||
Shelf Time | 24 months | |||
Xi'an Huawave Biotech Co., Ltd. is a professional Dalbavancin Hydrochloride/Dalbavancin HCL manufacturer and Dalbavancin Hydrochloride supplier . We are committed to providing customers with professional research and development, production and sales, as well as OEM and ODM processing services.
Dalbavancin Hydrochloride (also known as Gumycin) is a novel semi synthetic glycopeptide antibiotic, which is a derivative of teicoplanin analogs and belongs to the second generation of glycopeptide antibiotics. Its main functions and characteristics can be summarized as follows:
Dalbavancin Hydrochloride (also known as Gumycin) is a novel semi synthetic glycopeptide antibiotic, which is a derivative of teicoplanin analogs and belongs to the second generation of glycopeptide antibiotics. Its main functions and characteristics can be summarized as follows:
1、 Dalbavancin Hydrochloride Main benefits
Dalbavancin Hydrochloride is mainly used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by Gram positive bacteria (G ⁺ bacteria), including methicillin-resistant Staphylococcus aureus (MRSA). It exerts antibacterial effects by inhibiting the biosynthesis of G yeast cell walls and has a wide spectrum of antibacterial properties.
2、Dalbavancin Hydrochloride Antibacterial spectrum
G bacteria: including methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus aureus (MSSA), coagulase negative Staphylococcus (CoNS), streptococcus, etc.
Drug resistant G ⁺ pathogens: such as penicillin and ceftriaxone resistant Streptococcus pneumoniae, teicoplanin insensitive CoNS, non vanA enterococci, etc.
G ⁺ Anaerobic bacteria: also have antibacterial activity.
3、Dalbavancin Hydrochloride Pharmacokinetic properties
Long half-life: The half-life of Dalbavancin hydrochloride is as long as 174 hours, so Dalbavancin Hydrochloride can be administered once a week in clinical practice, improving the convenience of medication for patients.
Excellent antibacterial activity: Dalbavancin Hydrochloride has achieved good results in the treatment of catheter-related blood borne infections as well as skin and soft tissue infections.
4、Dalbavancin Hydrochloride Medication precautions
Adverse reactions: Dalbavancin hydrochloride has good tolerance, but some adverse reactions may also occur, such as nausea, headache, diarrhea, etc. During the medication process, Dalbavancin Hydrochloride is important to closely monitor the patient's reactions and promptly address them.
Special population medication: This product should only be used during pregnancy if the potential benefits outweigh the potential risks to the fetus. At the same time, it is not yet clear whether dabigatran hydrochloride or its metabolites are excreted in human breast milk, so lactating women should use it with caution. In addition, the safety and efficacy in pediatric patients have not yet been determined, and elderly patients are more likely to have reduced kidney function, so dosage selection should be careful in this age group.
Drug interactions: Currently, there have been no clinical studies on drug drug interactions using Dalbavancin hydrochloride. However, the potential for drug drug interactions between this product and cytochrome P450 (CYP450) substrates, inhibitors, or inducers is small.
5、Dalbavancin Hydrochloride Administration method
Dalbavancin hydrochloride is administered via intravenous infusion, typically for a total infusion time of 30 minutes, to reduce the risk of infusion related reactions. Rapid intravenous infusion may cause reactions similar to"red man syndrome", including upper body redness, urticaria, itching, and/or rash. Stopping or slowing down infusion may cause these reactions to stop.
In summary, Dalbavancin hydrochloride is a second-generation glycopeptide antibiotic with excellent in vivo antibacterial activity and safety, particularly suitable for the treatment of acute bacterial skin and skin structure infections caused by Gram positive bacteria. When using, medication guidelines and precautions should be strictly followed to ensure patient safety and efficacy.
Dalbavancin hydrochloride (also known as Dalbavancin or dauricin) is a novel glycopeptide antibiotic primarily used to treat infections caused by Gram positive bacteria (Gram positive bacteria). The following is a detailed explanation of its purpose:
1、Dalbavancin Hydrochloride Main purpose
Acute bacterial skin and skin structure infections (ABSSSI):
Dalbavancin Hydrochloride is mainly used to treat infections caused by sensitive bacteria, which typically include methicillin-resistant Staphylococcus aureus (MRSA) and other antibiotic resistant bacteria.
Other Gram positive bacterial infections:
In addition to ABSSSI, Dalbavancin hydrochloride can also be used to treat other infections caused by Gram positive bacteria, such as bloodstream infections, osteomyelitis, etc., but the specific use depends on the doctor's guidance and the patient's specific situation.
2、Dalbavancin Hydrochloride Advantages of medication
Broad spectrum antibacterial:
Dalbavancin Hydrochloride has a broad antibacterial spectrum and can cover a variety of Gram positive bacteria, including drug-resistant bacteria such as MRSA.
Long half-life:
This drug has a long half-life in the body, so it can reduce the frequency of administration and improve the convenience of medication for patients.
Security:
Dalbavancin hydrochloride has shown good safety and tolerability in clinical trials, but there may also be some adverse reactions such as nausea, headache, etc., which require close attention to patient reactions.
3、Dalbavancin Hydrochloride Precautions for use
Pre medication evaluation:
Before using Dalbavancin Hydrochloride hydrochloride, doctors need to conduct a comprehensive evaluation of the patient's infection status, allergy history, liver and kidney function, etc., to ensure the safety and effectiveness of the medication.
Administration method:
Dalbavancin hydrochloride is usually administered via intravenous infusion, typically for 30 minutes, to reduce the risk of infusion related reactions.
Monitoring and follow-up:
During the medication process, it is necessary to closely monitor the patient's condition changes, adverse reactions, etc., and adjust the treatment plan in a timely manner.
Medication for special populations:
For special populations such as pregnant women, breastfeeding women, children, and elderly patients, caution should be exercised when using Dalbavancin hydrochloride under the guidance of a doctor.
In summary, Dalbavancin hydrochloride is an antibiotic with broad-spectrum antibacterial properties, long half-life, and good safety. It is mainly used to treat infections caused by Gram positive bacteria. When using, it is necessary to strictly follow the doctor's guidance and medication precautions to ensure patient safety and efficacy.
You may also like